Clinical Trial Update: Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids [NA]

View source ↗

Summary

A completed clinical trial evaluated whether oral branched-chain amino acid supplementation can prevent liver tumorigenesis in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• branched-chain amino acids (branched-chain amino acids)

Snippet

Sponsor: Kochi University | Conditions: Liver Cancer | NA | Status: COMPLETED